The safety and effectiveness of a new hybrid ablation procedure to treat symptomatic Inappropriate Sinus Tachycardia (IST) is being evaluated in a new clinical trial. ​
​
If your patients have symptoms of IST and are resistant or intolerant to medications, they may be eligible for the HEAL-IST Trial. ​​

Visit HEAL-IST.com to learn more. ​​
<a href='https://www.linkedin.com/feed/hashtag/?keywords=IST&highlightedUpdateUr…; target='_blank'>#IST</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=Innapropriatesinustachy…; target='_blank'>#Innapropriatesinustachycardia</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=ClincialTrial&highlight…; target='_blank'>#ClincialTrial</a>​